Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Rodgers

Showing results (301-310 of 356) with videos related to

Pageof 36
Sort By:
Nature Medicine|October 10, 2022
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof studyChristian Razo, Catherine A Welgan, Catherine O Johnson, et al.
Headache|January 21, 2026
Patient perspectives on research gaps in cluster headacheFaraidoon Haghdoost, Dilara Bahceci, Candice Delcourt, et al.
BMC Public Health|August 7, 2010
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular riskHueiming Liu, Anushka Patel, Alex Brown, et al.
Hypertension (Dallas, Tex. : 1979)|June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAlexander Bennett, Clara K Chow, Michael Chou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Cephalalgia : an International Journal of Headache|June 23, 2023
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysisCheryl Carcel, Faraidoon Haghdoost, Joanne Shen, et al.
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
Pageof 36

Showing results (301-310 of 356) with videos related to

Sort By:
Pageof 36
Nature Medicine|October 10, 2022
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof studyChristian Razo, Catherine A Welgan, Catherine O Johnson, et al.
Headache|January 21, 2026
Patient perspectives on research gaps in cluster headacheFaraidoon Haghdoost, Dilara Bahceci, Candice Delcourt, et al.
BMC Public Health|August 7, 2010
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst indigenous and non indigenous people at high cardiovascular riskHueiming Liu, Anushka Patel, Alex Brown, et al.
Hypertension (Dallas, Tex. : 1979)|June 7, 2017
Efficacy and Safety of Quarter-Dose Blood Pressure-Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAlexander Bennett, Clara K Chow, Michael Chou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD TrialChloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Global Heart|February 19, 2024
Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of HypertensionAnthony Rodgers, Abdul Salam, William Cushman, et al.
Cephalalgia : an International Journal of Headache|June 23, 2023
The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysisCheryl Carcel, Faraidoon Haghdoost, Joanne Shen, et al.
The Lancet. Global Health|September 4, 2019
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trialThomas Lung, Stephen Jan, H Asita de Silva, et al.
Journal of the American Heart Association|June 22, 2023
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE TrialsRobert A Fletcher, Clare Arnott, Patrick Rockenschaub, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
Pageof 36